Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases Patrizia Burra; Calogero Cammà; Pietro Invernizzi; Fabio Marra; Maurizio Pompili;

Updated recommendations for the management of metabolic dysfunction¿associated steatotic liver disease (MASLD) by the Latin American working group. Luis Antonio Diaz; Juan Pablo Arab; Francisco Idalsoaga; Javiera Perelli; Javier Vega; Melisa Dirchwolf; Javiera Carreño; Bárbara Samith; Cynthia Valério; Rodrigo Oliveira Moreira; Mónica Acevedo; Javier Brahm; Nelia Hernández; Adrian Gadano; Claudia P. Oliveira; Marco Arrese; Graciela Castro-Narro; Mario G. Pessoa;

Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;